NanoViricides
NNVC
#10132
Rank
โ‚ฌ19.01 M
Marketcap
1,06ย โ‚ฌ
Share price
0.82%
Change (1 day)
-25.59%
Change (1 year)

Market capitalization of NanoViricides (NNVC)

Market cap: โ‚ฌ19.01 Million

As of December 2025 NanoViricides has a market cap of โ‚ฌ19.01 Million. This makes NanoViricides the world's 10132th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of NanoViricides from 2007 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ19.01 M-8.06%
2024โ‚ฌ20.68 M90.82%
2023โ‚ฌ10.83 M-9.79%
2022โ‚ฌ12.01 M-68.26%
2021โ‚ฌ37.85 M52.13%
2020โ‚ฌ24.88 M186.95%
2019โ‚ฌ8.67 M-28.63%
2018โ‚ฌ12.15 M-73.85%
2017โ‚ฌ46.45 M-21.54%
2016โ‚ฌ59.2 M-5.12%
2015โ‚ฌ62.4 M-50.67%
2014โ‚ฌ0.12 B-27.27%
2013โ‚ฌ0.17 B207.49%
2012โ‚ฌ56.56 M-19.36%
2011โ‚ฌ70.15 M-54.27%
2010โ‚ฌ0.15 B96%
2009โ‚ฌ78.26 M10.08%
2008โ‚ฌ71.09 M123.39%
2007โ‚ฌ31.82 M

End of Day market cap according to different sources

On Dec 6th, 2025 the market cap of NanoViricides was reported to be:

โ‚ฌ19.01 Million
by Nasdaq info icon info icon
โ‚ฌ19.01 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
BioCryst Pharmaceuticals
BCRX
โ‚ฌ1.37 B 7,119.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚ฌ0.96 B 4,972.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ129.18 B 679,374.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ91.18 B 479,494.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚ฌ213.93 B 1,125,105.40%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ83.93 B 441,340.07%๐Ÿ‡ฌ๐Ÿ‡ง UK